Related Experiment Video
Updated: Jul 7, 2026

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Affordable pediatric CD4 counting by flow cytometry in Malawi.
Calman A Maclennan1, Felix Dzumani, Alinane Namarika
1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi. c.maclennan@bham.ac.uk
Cytometry. Part B, Clinical Cytometry
|March 1, 2008
Summary
The Blantyre count method accurately measures CD4 percentages in HIV-positive children in Malawi. This affordable flow cytometry technique is reliable and can be performed by local technicians.
Area of Science:
- Clinical Immunology
- Flow Cytometry
- Pediatric Infectious Diseases
Background:
- Antiretroviral therapy expansion in Malawi lacks adequate pediatric CD4 counting facilities.
- A simplified, affordable Blantyre count flow cytometry method was validated in adults.
- Need to validate the Blantyre count method for pediatric use in government labs.
Purpose of the Study:
- To assess the agreement of the Blantyre count method with the Panleucogate method for pediatric CD4+ T-lymphocyte percentage (%CD4) determination.
- To validate the Blantyre count method for use by local laboratory technicians in Malawi.
Main Methods:
- 113 blood samples from HIV-seropositive children in Malawi were analyzed.
- Comparison of %CD4 values using the Blantyre count and Panleucogate methods on an EPICS XL-MCL flow cytometer.
- Assays were performed by two Malawian laboratory technicians.
Main Results:
- The Blantyre count showed minimal bias (-0.13%) and acceptable limits of agreement (-2.69% to 2.43%) compared to Panleucogate.
- Results were consistent across laboratory technicians, with limits of agreement within -3.00% and 3.00%.
- The Blantyre count assay demonstrated good sample stability over 5 days with a 2.0% coefficient of variation.
Conclusions:
- The Blantyre count method accurately determines pediatric %CD4/lymphocyte values using an EPICS XL-MCL flow cytometer.
- The assay is cost-effective at $0.21 per test and can be competently performed by local laboratory technicians.
- This validated method supports improved pediatric HIV care in resource-limited settings.

